Evolv GLP-1 is an oral biomimetic peptide delivered inside inactivated yeast, the most scientifically ambitious product in this category and the one with the least clinical evidence.
Overview
Evolv launched with what it describes as the first oral biomimetic GLP-1 supplement. Its flagship contains a single active ingredient, the EV1 Peptide, which the company states is composed solely of canonical amino acids. The peptide is delivered inside inactivated Saccharomyces cerevisiae, a brewer's yeast strain designated EV1, which the company says carries a proprietary peptide dose within the yeast cell. Evolv also sells a GHK-Cu product aimed at hair thickness, which addresses a genuine and frequently reported GLP-1 complaint.
The yeast delivery approach is the interesting part and is not marketing decoration. Oral peptides are difficult precisely because the digestive tract exists to break peptides into amino acids, which is why GLP-1 medications are injected or, in the case of oral semaglutide, require an absorption enhancer and careful dosing conditions. Encapsulating a peptide inside a yeast cell wall is a plausible strategy for getting it past the stomach. Evolv claims a half-life of one to two days for the resulting peptide, which if accurate would be a meaningful property.
The gap is evidence. Coverage in AgFunderNews, BusinessWire and specialist bioeconomy press describes the technology and the company's claims, but none of it constitutes a published human trial demonstrating that the peptide reaches circulation intact, engages GLP-1 receptors at a meaningful level, or produces any clinical outcome. The biomimetic framing also invites a comparison with injectable medication that no supplement can currently support. A Reddit reviewer described it as helping stimulate their natural GLP-1 hormone and being cheaper than an injection through insurance, which is a reasonable personal account and not evidence of mechanism.
Evolv GLP-1 Oral Peptide at a Glance
| Detail | What Evolv GLP-1 Oral Peptide Publishes |
|---|---|
| Type of product | Dietary supplement, oral biomimetic peptide |
| Active ingredient | EV1 Peptide, composed of canonical amino acids |
| Delivery system | Inactivated Saccharomyces cerevisiae yeast, strain EV1 |
| Claimed half-life | One to two days |
| Number of actives | One, which is unusually focused for this category |
| Published human trial | None |
| Company status | Newly launched, covered by AgFunderNews and BusinessWire |
| Companion product | GHK-Cu for hair thickness |
| Where sold | Direct from Evolv |
| FDA evaluated | No, as with all dietary supplements |
What Is Actually in It
- The EV1 Peptide as a single named active ingredient
- Delivery inside inactivated Saccharomyces cerevisiae yeast
- A peptide built from canonical amino acids rather than novel chemistry
- A claimed one to two day half-life
- A once-daily tablet format
- A separate GHK-Cu product for hair, sold alongside
Supplement or Medication?
A dietary supplement, though it is closer to the boundary than anything else in this category. It contains an actual peptide rather than a plant extract, and the company describes it as engaging GLP-1 receptors. Without published human data confirming absorption and receptor engagement, that description remains a claim rather than a demonstrated property.
How You Buy It
Buy direct
Sold through Evolv's own site.
Take the daily tablet
One tablet containing the yeast-encapsulated peptide.
Understand what you are buying
There is no published human trial on this product.
Consider the companion product
Evolv also sells GHK-Cu for hair, a common GLP-1 concern.
Who It Is Sold To
- Adults comfortable being early adopters of a novel technology
- No consultation or clinical assessment involved
- Yeast-based delivery may not suit people with yeast sensitivities
- Not appropriate as a substitute for prescribed obesity treatment
- Speak to a clinician first if you take glucose-lowering medication
- Anyone wanting proven efficacy should look elsewhere for now
Clinical Oversight and Evidence
Clinical Oversight
None. This is a direct-to-consumer supplement with no clinical involvement. Given that the product contains a peptide intended to engage GLP-1 receptors, telling your prescriber you are taking it is more important here than with a botanical product.
Evidence
The weakest part of an otherwise interesting proposition. There is no published human trial demonstrating absorption, receptor engagement or clinical outcome. Trade coverage in AgFunderNews and BusinessWire describes the technology and the company's own claims. The one to two day half-life figure comes from the company and has not been independently verified in published literature.
Availability and Shipping
Where to Buy
Direct from Evolv. As a newly launched brand it does not have retail distribution.
Shipping
Direct-to-consumer shipping. Shelf-stable tablets containing inactivated yeast.
What You Get
- A single named active ingredient rather than a blend
- Published technical explanation of the delivery mechanism
- Trade press coverage of the underlying technology
- A companion product addressing GLP-1 related hair thinning
- Direct customer service through the company
- No published human trial, and no clinical support
Pricing
Direct-to-consumer pricing from a newly launched company, with subscription options.
| Product or Plan | Published Price | What It Covers |
|---|---|---|
| Evolv GLP-1 | Direct pricing | Once-daily oral biomimetic peptide |
| Evolv GHK-Cu | Sold separately | For hair thickness |
| Subscription | Available | Managed through your Evolv account |
| Retail | None | Sold direct only |
Pricing reflects what Evolv GLP-1 Oral Peptide published at the time of review and can change without notice. Confirm current pricing directly with the seller before buying.
Membership Fees
None. Subscription is optional and reduces the unit price rather than granting access to anything.
Annual Cost
Direct-to-consumer annual cost, which for a product without a published human trial is worth weighing against better-evidenced alternatives.
Cancellation and Refund Policy
Cancellation
Subscriptions are managed through your Evolv account.
Refunds
Evolv operates its own direct-to-consumer returns policy.
Insurance, HSA and FSA
Insurance
Not applicable to a retail supplement.
HSA / FSA
Generally not eligible. Dietary supplements are usually excluded from HSA and FSA spending without a letter of medical necessity from a clinician.
For a fuller explanation of how these accounts work with GLP-1 care, see our GLP-1 insurance, HSA and FSA guide.
Who Evolv GLP-1 Oral Peptide May Be Best For
- You find the yeast-encapsulated peptide approach genuinely interesting
- You want a single named active rather than a botanical blend
- You are comfortable being an early adopter
- You want the most novel thing in the category rather than the safest bet
- You are also dealing with GLP-1 related hair thinning
- You understand that no human trial has been published
- No published human trial on the product at all
- The claimed half-life is unverified outside the company's own material
- Oral peptide delivery remains an unsolved problem in general
- A very new company with no track record to assess
- Biomimetic framing invites unrealistic comparisons with medication
- Sold direct only, with no retail route
Alternatives to Consider
Force Factor Super GLP-1 Support
Less novel, but with published human trials behind its ingredient.
Ora Organic GLP-1 Up
Patented extracts with individual clinical studies.
Supergut GLP-1 Daily Support
The largest randomised trial in the category.
Calocurb
Amarasate hops extract with published appetite trials.
You can also compare the whole field in our best GLP-1 supplements and GLP-1 supplement evidence review roundups.
Frequently Asked Questions
What is the EV1 Peptide?
Evolv describes it as a peptide composed solely of canonical amino acids, delivered inside inactivated Saccharomyces cerevisiae yeast designated as the EV1 strain. It is the single active ingredient in the product.
Why deliver a peptide inside yeast?
Because digestion normally destroys peptides. That is why GLP-1 medications are injected, or in the case of oral semaglutide require an absorption enhancer and strict dosing conditions. Encapsulating the peptide inside a yeast cell wall is a plausible attempt at getting it through the stomach intact.
Is there a human trial?
No. This is the central weakness. No published trial demonstrates that the peptide reaches circulation, engages GLP-1 receptors, or produces a clinical outcome.
Is it the same as taking a GLP-1 medication?
No. It is a dietary supplement, and without published absorption data there is no basis for comparing it with a prescription medication.
What is the claimed half-life?
Evolv states one to two days. That figure comes from the company and has not been independently verified in published literature.
Why does Evolv also sell a hair product?
GHK-Cu is aimed at hair thickness, which addresses hair thinning, a frequently reported complaint among people losing weight rapidly on GLP-1 medication.
Is it FDA approved?
No. It is a dietary supplement, so it does not require FDA approval before marketing and its claims have not been evaluated by the FDA.